Lexaria Days Of Payables Outstanding from 2010 to 2024

LEXXW Stock  USD 0.78  0.03  4.00%   
Lexaria Bioscience Days Of Payables Outstanding yearly trend continues to be fairly stable with very little volatility. Days Of Payables Outstanding will likely drop to 42.94 in 2024. During the period from 2010 to 2024, Lexaria Bioscience Days Of Payables Outstanding regression line of quarterly data had mean square error of 390.8 M and geometric mean of  456.79. View All Fundamentals
 
Days Of Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
80.1 K
Current Value
42.94098747
Quarterly Volatility
20.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 125.2 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Days Of Payables Outstanding Growth Pattern

Below is the plot of the Days Of Payables Outstanding of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Days Of Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Days Of Payables Outstanding10 Years Trend
Slightly volatile
   Days Of Payables Outstanding   
       Timeline  

Lexaria Days Of Payables Outstanding Regression Statistics

Arithmetic Mean5,800
Geometric Mean456.79
Coefficient Of Variation354.44
Mean Deviation9,903
Median403.96
Standard Deviation20,557
Sample Variance422.6M
Range80K
R-Value0.38
Mean Square Error390.8M
R-Squared0.14
Significance0.17
Slope1,727
Total Sum of Squares5.9B

Lexaria Days Of Payables Outstanding History

2024 42.94
202380.1 K
2022 2607.58
2021 131.32
2020 124.67
2019 165.57
2018 501.64

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Days Of Payables Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Payables Outstanding80.1 K42.94

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.